IGF-1R antibody and its use for the diagnosis of cancer

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 10753937
APP PUB NO 20190049457A1
SERIAL NO

15569566

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present disclosure relates to IGF-IR (insulin like growth factor receptor-1) antibodies characterized by CDR sequences a, to be used in detection methods of IGF-IR expressing tumoral cells.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
PIERRE FABRE MEDICAMENT45 PLACE ABEL GANCE BOULOGNE-BILLANCOURT 92100

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Jouhanneaud, Alexandra Bonneville, FR 19 57

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Feb 25, 2028
11.5 Year Payment $7400.00 $3700.00 $1850.00 Feb 25, 2032
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00